In addition, because individuals with single autoantibodies have a lower risk of developing T1D with respect to those with multiple autoantibodies, it is possible that these subjects, in the absence of this TCF7L2 variant, may not develop overt diabetes [105]. This evidence concerns the gene TCF7L2 and diabetes mellitus.